Dynavax Technologies Corporation dynavax.com


Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Our TLR9 agonists are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic in...Show all

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases using versatile, proprietary appr...Show all

Company (IPO / Went public)

Phone: 510-848-5100

Fax:

2929 Seventh Street
Suite 100
Berkeley, 94710
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Dynavax Technologies Corporation $125.7M Feb 19, 2004
Bayhill Therapeutics $97.4M Jun 11, 2011
Inhibitex $209.8M Aug 12, 2005
See all 29 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Dynavax Technologies Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors

Competitors

Company Status Description Investors
See all 29 competitors